Untitled Document

ANDROSCORE CORPORATION

Provides home use diagnostic kits to test the fertility of human males (FertilitySCORE®), bulls (BullSCORE), stallions (StudSCORE) and boars (BoarSCORE) .

NOTICE TO INTERNATIONAL MARKETERS: Inquiries as to how to obtain the right to market these products in respective countries should be directed to Androscore Corporation.

FertilitySCORE: Home Use Medical Device to Test Male Fertility

FertilitySCORE is the patented property of Androscore Corporation, a R & D company located in Texas and Montana, USA . We develop products in the field of male reproduction but do not market our products. FertilitySCORE is sold as an OTC home use medical device to test male fertility in more than 30 countries throughout the world.

FertilitySCORE tests the entire semen sample for greater accuracy and there are two tests in each product (see below) . The number of motile sperm per ml is the end point as sperm motility is the semen parameter most closely correlated with fertility. As this test is a screen, men can evaluate their semen quality at home without going to a medical clinic. It is a color test with color changes associated with the number of motile sperm per ml. Instructions are simple and easily followed.

Now that we have successfully established FertilitySCORE in some countries in Europe, Asia and Africa we want to expand the market, especially the United States. As an OTC medical device to test male fertility is a new category, medical device manufacturers are not familiar with it or the size of the market, etc. This will change - as it has in Europe - logon to Google and type in FertilitySCORE to learn the degree of interest and many distributors that sell FertilitySCORE.

We still seek distributors for eastern European countries, Africa, Latin & South America and the US market - one that is capable of getting FertilitySCORE shelf space in major retail outlets for home use medical devices. The US market, for this type of medical device, is the largest in the world and we are now ready to enter this market.

FertilitySCORE®

Protected by U.S. Patent 5,068,089 and like patent in other countries.

(Ronald J. Ericsson, PhD & Scott A. Ericsson, PhD - co-inventors)

(Click for Larger Image)

FertilitySCORE Kits contains two tests. It is a simple color test that can be done at home. A positive or negative result is determined by a change or lack of change of color of the semen sample when compared to a color chart.

A couple is considered infertile if pregnancy does not occur after 12 months of unprotected intercourse. Infertility affects approximately 10 to 15% of all couples in the reproductive age group and 40 to 50% of infertility is due to problems with sperm.

The male factor is most commonly assessed by semen analysis in which sperm concentration, sperm motility and sperm morphology are determined. All have a bearing on fertility with the concentration of motile sperm correlating best with subsequent fertility.

The great majority of men with concentrations of 20 million motile sperm per ml or greater are fertile whereas concentrations of 10 million motile sperm per ml or less are more frequently associated with infertility.

In a clinical study the FertilitySCORE Kit was compared to the concentration of motile spermatozoa. A 93% positive predictive power was found for semen samples containing 20 million or more motile sperm per ml. A 90% negative predictive power was found for semen samples containing 10 million motile sperm or less per ml. Thus the FertilitySCORE Kit is a highly effective screening test for male fertility potential.

1. Glass RH, Ericsson SA, Ericsson RJ, Marcoux, LJ and Sullivan H. The resazurin reduction test provides an assessment of sperm activity. Fert. Steril. 56: 743-746, 1991.

2. Mahmoud AM, Comhaire FH, Vermeulen L and Andreou E. Comparison of the resazurin test, adenosine triphosphate in semen, and various sperm parameters. Hum. Reprod. 9(9): 1688-1693, 1994.

3. Dart MG, Mesta J, Crenshaw C and Ericsson SA. Modified resazurin reduction test for determining the fertility potential of bovine spermatozoa. Arch. Androl. 33: 71-75, 1994.

4. Reddy KV, Meherji PK, Gokral JS and Shahani SK. Resazurin reduction test to evaluate semen quality. Indian J. Exp. Biol. 35(4): 369-373, 1997.

5. Zalata AA, Lammertijn N, Christophe A and Comhaire FH. The correlates and alleged biochemical background of the resazurin reduction test in semen. Int. J. Androl. 5: 289-294, 1998.

FertilitySCORE DISTRIBUTORS